# US 2022/0033852 A1 · RNA Replicon for Versatile and Efficient Gene Expression

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0033852 A1
- Document ID: US20220033852A1
- Status: Published application
- Kind: A1
- Application number: 17/494,601
- Filed: 2021-10-05
- Published: 2022-02-03
- Earliest claimed: 2016-03-21
- Assignees: BioNTech RNA Pharmaceuticals GmbH; TRON-Translationale Onkologie an der Universitätsmedizin der Johanne Gutenberg-Universität Mainz gem
- Applicants: Biontech Rna Pharmaceuticals GmbH; TRON-Translationale Onkologie an der Universitätsmedizin der Johanne Gutenberg-Universität Mainz gem
- Inventors: Tim Beissert; Ugur Sahin; Mario Perkovic
- Web page: https://patentgrep.com/patent/US20220033852A1

## CPC

- C12N 15/86: Viral vectors
- A61K 35/76: Viruses; Subviral particles; Bacteriophages
- C12N 2770/36143: viral genome or elements thereof as genetic vector
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention embraces a RNA replicon that can be replicated by a replicase of alphavirus origin. The RNA replicon comprises sequence elements required for replication by the replicase, but these sequence elements do not encode any protein or fragment thereof, such as an alphavirus non-structural protein or fragment thereof. Thus, in the RNA replicon according to the invention, sequence elements required for replication by the replicase and protein-coding region(s) are uncoupled. According to the present invention the uncoupling is achieved by the removal of at least one initiation codon compared to a native alphavirus genomic RNA. In particular, the RNA replicon comprises a 5′ replication recognition sequence, wherein the 5′ replication recognition sequence is characterized in that it comprises the removal of at least one initiation codon compared to a native alphavirus 5′ replication recognition sequence. The replicase of alphavirus origin may be encoded by an open reading frame on the RNA replicon or on a separate RNA molecule. The present invention enables efficient and safe expression of a protein of interest in a cell or organism, but is not associated with undesired production of fragments of alphavirus non-structural protein. Methods of protein production in vitro and in vivo, as well as medical uses, are provided herein.

## Claims

### Claim 1

A RNA replicon comprising a 5′ replication recognition sequence, wherein the 5′ replication recognition sequence is characterized in that it comprises the removal of at least one initiation codon compared to a native alphavirus 5′ replication recognition sequence.

### Claim 2 (depends on 1)

The RNA replicon according to claim 1, wherein the 5′ replication recognition sequence comprises a sequence homologous to about 250 nucleotides at the 5′ end of an alphavirus, and preferably comprises a sequence homologous to about 300 to about 500 nucleotides at the 5′ end of an alphavirus.

### Claim 3 (depends on 1, 2)

The RNA replicon according to claim 1 or 2, wherein the 5′ replication recognition sequence comprises sequences homologous to conserved sequence element 1 and conserved sequence element 2 of an alphavirus.

### Claim 4 (depends on 3)

The RNA replicon according to claim 3, wherein conserved sequence element 2 comprises a fragment of an open reading frame of a non-structural protein from an alphavirus.

### Claim 5 (depends on 1, 2, 3, 4)

The RNA replicon according to any one of claims 1 to 4, wherein the 5′ replication recognition sequence comprises a sequence homologous to an open reading frame of a non-structural protein or a fragment thereof from an alphavirus, wherein the sequence homologous to an open reading frame of a non-structural protein or a fragment thereof from an alphavirus is characterized in that it comprises the removal of at least one initiation codon compared to the native alphavirus sequence.

### Claim 6 (depends on 5)

The RNA replicon according to claim 5, wherein the sequence homologous to an open reading frame of a non-structural protein or a fragment thereof from an alphavirus is characterized in that it comprises the removal of at least the native start codon of the open reading frame of a non-structural protein.

### Claim 7 (depends on 5, 6)

The RNA replicon according to claim 5 or 6, wherein the sequence homologous to an open reading frame of a non-structural protein or a fragment thereof from an alphavirus is characterized in that it comprises the removal of one or more initiation codons other than the native start codon of the open reading frame of a non-structural protein.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The RNA replicon according to any one of claims 1 to 7, which comprises one or more nucleotide changes compensating for nucleotide pairing disruptions within one or more stem loops introduced by the removal of at least one initiation codon.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The RNA replicon according to any one of claims 1 to 8, which does not comprise an open reading frame encoding a truncated alphavirus non-structural protein.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The RNA replicon according to any one of claims 1 to 9, which comprises a 3′ replication recognition sequence.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The RNA replicon according to any one of claims 1 to 10, which comprises a first open reading frame encoding a protein of interest.

### Claim 12 (depends on 11)

The RNA replicon according to claim 11, wherein the protein of interest encoded by the first open reading frame can be expressed from the RNA replicon as a template.

### Claim 13 (depends on 11, 12)

The RNA replicon according to claim 11 or 12, which comprises a subgenomic promoter controlling production of subgenomic RNA comprising the first open reading frame encoding a protein of interest.

### Claim 14 (depends on 13)

The RNA replicon according to claim 13, wherein the protein of interest encoded by the first open reading frame can be expressed from the RNA replicon and the subgenomic RNA.

### Claim 15 (depends on 11, 12)

The RNA replicon according to claim 11 or 12, which comprises a subgenomic promoter controlling production of subgenomic RNA comprising a second open reading frame encoding a protein of interest.

### Claim 16 (depends on 15)

The RNA replicon according to claim 15, wherein the subgenomic promoter and the second open reading frame encoding a protein of interest are located downstream from the first open reading frame encoding a protein of interest.

### Claim 17 (depends on 11, 12, 13, 14, 15, 16)

The RNA replicon according to any one of claims 11 to 16, wherein the protein of interest encoded by the first and/or second open reading frame is functional alphavirus non-structural protein.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The RNA replicon according to any one of claims 1 to 17, which comprises an open reading frame encoding functional alphavirus non-structural protein.

### Claim 19 (depends on 17, 18)

The RNA replicon according to claim 17 or 18, wherein the open reading frame encoding functional alphavirus non-structural protein does not overlap with the 5′ replication recognition sequence.

### Claim 20 (depends on 17, 18, 19)

The RNA replicon according to any one of claims 17 to 19, which can be replicated by the functional alphavirus non-structural protein.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The RNA replicon according to any one of claims 1 to 16, which does not comprise an open reading frame encoding functional alphavirus non-structural protein.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 21)

A system comprising:
a RNA construct for expressing functional alphavirus non-structural protein,
the RNA replicon according to any one of claims 1 to 16 and 21 which can be replicated by the functional alphavirus non-structural protein in trans.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The RNA replicon according to any one of claims 1 to 21 or the system according to claim 22, wherein the alphavirus is Semliki Forest Virus.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 23)

A DNA comprising a nucleic acid sequence encoding the RNA replicon of any one of claims 1 to 21 and 23.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 23)

A method for producing a protein of interest in a cell comprising the steps of:
(a) obtaining the RNA replicon according to any one of claims 1 to 20 and 23 which comprises an open reading frame encoding functional alphavirus non-structural protein, can be replicated by the functional alphavirus non-structural protein and comprises an open reading frame encoding the protein of interest, and
(b) inoculating the RNA replicon into the cell.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 21, 23)

A method for producing a protein of interest in a cell comprising the steps of:
(a) obtaining a RNA construct for expressing functional alphavirus non-structural protein,
(b) obtaining the RNA replicon according to any one of claims 1 to 16, 21 and 23 which can be replicated by the functional alphavirus non-structural protein in trans and comprises an open reading frame encoding the protein of interest, and
(c) co-inoculating the RNA construct for expressing functional alphavirus non-structural protein and the RNA replicon into the cell.

### Claim 27 (depends on 25, 26)

A cell inoculated according to the method of claim 25 or 26.

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 23)

A method for producing a protein of interest in a subject comprising the steps of:
(a) obtaining the RNA replicon according to any one of claims 1 to 20 and 23 which comprises an open reading frame encoding functional alphavirus non-structural protein, can be replicated by the functional alphavirus non-structural protein and comprises an open reading frame encoding the protein of interest, and
(b) administering the RNA replicon to the subject.

### Claim 29 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 21, 23)

A method for producing a protein of interest in a subject comprising the steps of:
(a) obtaining a RNA construct for expressing functional alphavirus non-structural protein,
(b) obtaining the RNA replicon according to any one of claims 1 to 16, 21 and 23 which can be replicated by the functional alphavirus non-structural protein in trans and comprises an open reading frame encoding the protein of interest, and
(c) administering the RNA construct for expressing functional alphavirus non-structural protein and the RNA replicon to the subject.
